BRINSUPRI

BRENSOCATIB · Insmed Incorporated

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BRINSUPRI, covering 2025-08-12 to 2025-12-04. Get the full timeline:

Most recent: EMA Authorised: Brinsupri (Brensocatib monohydrate) — Insmed Netherlands B.V.